Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HSDL2 |
| Upstream (Parents) |
|---|
| (<<) EHHADH → HSDL2 |
| (<<) ETFDH → HSDL2 |
| (<<) SLC37A4 → HSDL2 |
| Downstream (Children) |
|---|
| HSDL2 → DHRS2 (>>) |
| HSDL2 → CXCR1 (>>) |
| HSDL2 → CA14 (>>) |
| HSDL2 → ARHGEF4 (>>) |
| HSDL2 → FZD2 (>>) |
| HSDL2 → MAPK4 (>>) |
| HSDL2 → CA7 (>>) |
| HSDL2 → GRRP1 (>>) |
| HSDL2 → ADK (>>) |
| HSDL2 → TPM4 (>>) |
| HSDL2 → AK3L2///AK4 (>>) |
| HSDL2 → FAM30A (>>) |
| HSDL2 → PVRL3 (>>) |
| HSDL2 → PDE3B (>>) |
